menu search

PEPG / PepGen Announces Presentations at the 2023 Myotonic Dystrophy Foundation Annual Conference, Ottawa Neuromuscular Disease Meeting, and H.C. Wainwright 25th Annual Global Investment Conference

PepGen Announces Presentations at the 2023 Myotonic Dystrophy Foundation Annual Conference, Ottawa Neuromuscular Disease Meeting, and H.C. Wainwright 25th Annual Global Investment Conference
BOSTON, Sept. 01, 2023 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that it will be presenting at upcoming medical meetings and an investor conference. Ashling Holland, Director of Preclinical Development at PepGen, will be giving a talk titled “PGN-EDODM1 nonclinical data demonstrated mechanistic and meaningful activity for the potential treatment of myotonic dystrophy type 1 (DM1)”, at the 2023 Myotonic Dystrophy Foundation Annual Conference, on September 9, 2023, in Washington, D.C. Read More
Posted: Sep 1 2023, 08:00
Author Name: GlobeNewsWire
Views: 042215

PEPG News  

PepGen Announces Presentations at the 2023 Myotonic Dystrophy Foundation Annual Conference, Ottawa Neuromuscular Disease Meeting, and H.C. Wainwright 25th Annual Global Investment Conference

By GlobeNewsWire
September 1, 2023

PepGen Announces Presentations at the 2023 Myotonic Dystrophy Foundation Annual Conference, Ottawa Neuromuscular Disease Meeting, and H.C. Wainwright 25th Annual Global Investment Conference

BOSTON, Sept. 01, 2023 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonu more_horizontal

PepGen Inc (PEPG) Q4 2022 Earnings Call Transcript

By Seeking Alpha
March 25, 2023

PepGen Inc (PEPG) Q4 2022 Earnings Call Transcript

PepGen Inc (NASDAQ:PEPG ) Q4 2022 Earnings Conference Call March 23, 2023 4:30 PM ET Company Participants Noel Donnelly - Chief Financial Officer Jame more_horizontal

PepGen, Inc. (PEPG) Is a Great Choice for 'Trend' Investors, Here's Why

By Zacks Investment Research
February 27, 2023

PepGen, Inc. (PEPG) Is a Great Choice for 'Trend' Investors, Here's Why

PepGen, Inc. (PEPG) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It more_horizontal

Here's Why Momentum in PepGen, Inc. (PEPG) Should Keep going

By Zacks Investment Research
January 31, 2023

Here's Why Momentum in PepGen, Inc. (PEPG) Should Keep going

PepGen, Inc. (PEPG) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. more_horizontal

What Makes PepGen, Inc. (PEPG) a Good Fit for 'Trend Investing'

By Zacks Investment Research
November 21, 2022

What Makes PepGen, Inc. (PEPG) a Good Fit for 'Trend Investing'

PepGen, Inc. (PEPG) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. more_horizontal

Andreas Halvorsen's Firm Packs Into PepGen and Mastercard

By GuruFocus
May 23, 2022

Andreas Halvorsen's Firm Packs Into PepGen and Mastercard

Andreas Halvorsen (Trades, Portfolio), founding partner and chief investment officer of Viking Global Investors LP, disclosed in a regulatory SEC 13G more_horizontal


Search within

Pages Search Results: